Myasthenia gravis constitutes chronic autoimmune ailment that primarily affects the neuromuscular junction. This junction facilitates the transmission of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system erroneously attacks these receptors, leading weakness and fatigue in the motor units. The indicat